The viability of the CD11c– keratinocyte and fibroblast population was 68% ± 4% and was similar to the viability of this cell population in OME (73% ± 4%), whereas the MDM CD11c+ viability in MDM-OME was 67% ± 8% (Fig. 3C, D). The gene discussed is ITGAX; the disease is otitis media with effusion.